Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kirchhoff

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
European Radiology|May 20, 2006
Preoperative volume calculation of the hepatic venous draining areas with multi-detector row CT in adult living donor liver transplantation: Impact on surgical procedureBernd B J Frericks, Timm D Kirchhoff, Hoen-Oh Shin, et al.
Journal of Medicinal Chemistry|March 29, 2012
Structure-based design of novel benzoxazinorifamycins with potent binding affinity to wild-type and rifampin-resistant mutant Mycobacterium tuberculosis RNA polymerasesSumandeep K Gill, Hao Xu, Paul D Kirchhoff, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|June 6, 2007
Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survivalTimm D Kirchhoff, Joerg S Bleck, Arne Dettmer, et al.
Journal of Medicinal Chemistry|September 2, 2021
Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate CancerWeiguo Xiang, Lijie Zhao, Xin Han, et al.
European Radiology|December 11, 2003
3D CT modeling of hepatic vessel architecture and volume calculation in living donated liver transplantationBernd B Frericks, Franco C Caldarone, Björn Nashan, et al.
Journal of Virology|July 18, 2014
Novel indole-2-carboxamide compounds are potent broad-spectrum antivirals active against western equine encephalitis virus in vivoPhillip C Delekta, Craig J Dobry, Janice A Sindac, et al.
World Journal of Gastroenterology|June 15, 2006
Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinomaArne Dettmer, Timm-D Kirchhoff, Michael Gebel, et al.
Journal of Medicinal Chemistry|September 23, 2024
Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC DegraderAtsunori Kaneshige, Yiqing Yang, Longchuan Bai, et al.
Nature Chemical Biology|February 2, 2023
A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivoAtsunori Kaneshige, Longchuan Bai, Mi Wang, et al.
Journal of Medicinal Chemistry|April 7, 2016
Structure-Based Design, Synthesis, and Biological Evaluation of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 InhibitorsHelen V Waldschmidt, Kristoff T Homan, Osvaldo Cruz-Rodríguez, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
European Radiology|May 20, 2006
Preoperative volume calculation of the hepatic venous draining areas with multi-detector row CT in adult living donor liver transplantation: Impact on surgical procedureBernd B J Frericks, Timm D Kirchhoff, Hoen-Oh Shin, et al.
Journal of Medicinal Chemistry|March 29, 2012
Structure-based design of novel benzoxazinorifamycins with potent binding affinity to wild-type and rifampin-resistant mutant Mycobacterium tuberculosis RNA polymerasesSumandeep K Gill, Hao Xu, Paul D Kirchhoff, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|June 6, 2007
Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survivalTimm D Kirchhoff, Joerg S Bleck, Arne Dettmer, et al.
Journal of Medicinal Chemistry|September 2, 2021
Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate CancerWeiguo Xiang, Lijie Zhao, Xin Han, et al.
European Radiology|December 11, 2003
3D CT modeling of hepatic vessel architecture and volume calculation in living donated liver transplantationBernd B Frericks, Franco C Caldarone, Björn Nashan, et al.
Journal of Virology|July 18, 2014
Novel indole-2-carboxamide compounds are potent broad-spectrum antivirals active against western equine encephalitis virus in vivoPhillip C Delekta, Craig J Dobry, Janice A Sindac, et al.
World Journal of Gastroenterology|June 15, 2006
Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinomaArne Dettmer, Timm-D Kirchhoff, Michael Gebel, et al.
Journal of Medicinal Chemistry|September 23, 2024
Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC DegraderAtsunori Kaneshige, Yiqing Yang, Longchuan Bai, et al.
Nature Chemical Biology|February 2, 2023
A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivoAtsunori Kaneshige, Longchuan Bai, Mi Wang, et al.
Journal of Medicinal Chemistry|April 7, 2016
Structure-Based Design, Synthesis, and Biological Evaluation of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 InhibitorsHelen V Waldschmidt, Kristoff T Homan, Osvaldo Cruz-Rodríguez, et al.
Pageof 7